Skip to main content
. 2016 Apr 21;19(1):91–104. doi: 10.1007/s12094-016-1508-y

Fig. 1.

Fig. 1

Current profile of breast cancer patients attended by the Spanish Delphi panel. Results are presented as a mean percentage (%; 95 % CI) of early-stage breast cancer patients (ESBC; 95 % CI 55–66); or metastatic breast cancer patients (MBC; 95 % CI 33.4–47.2) treated with chemotherapy, and those who refers at least one risk factor (RF) to develop cardiotoxicity (ESBC + RF, 95 % CI 30.3–40.2; MBC + RF, 95 % CI 47.2–58.9)